Attachment D - VHA MSPV Supplies RFI - 36C24125Q0470 - Industry Day - Transcript Summary.pdf

VHA MSPV Supplies RFI – 36C24125Q0470 – Industry Day – Transcript Summary

### Introduction:

**Jeremy Parker** addressed the attendees of the VHA MSPV Supplies RFI Industry Day, outlining the purpose of the event which focused on cleaning up data for an upcoming solicitation. Various key personnel, including **Damon Ware**, **Crystal Martin**, and other members of the commodities team, were introduced.

### Key Points:

1. **Purpose of Industry Day:** To clean up data for the Supplies RFI and ensure accurate and compliant responses.

2. **Introduction of Key Personnel:** Jeremy Parker, Damon Ware, Crystal Martin, and others were introduced.

3. **MSPV Program Overview:** The MSPV program is aimed at providing an efficient and cost-effective method for ordering and distributing supplies across VHA facilities via prime vendors like Medline and Concordance.

4. **RFI Purpose:** Clean up data including discontinued items, incorrect information, TA compliance, private label issues, pharmaceutical items, DME, and prosthetic implants.

5. **Instructions for RFI Spreadsheet:** Detailed guidelines on how to update and submit the spreadsheet with accurate data were provided.

### Questions and Answers:

**Question 1:**

- **Person Asking:** Angelica Caetano

- **Person Answering:** Jeremy Parker

- **Question:** Products listed as pharmaceutical on my spreadsheet are not med-surg, what should be done?

- **Answer:** Mark them on the response spreadsheet and specify the contract they're under; they will be reviewed and likely removed.

**Question 2:**

- **Person Asking:** Yolanda Data Davis

- **Person Answering:** Jeremy Parker

- **Question:** Can a small business manufacturer submit information for a non-brand item listed on the RFI?

- **Answer:** Currently, responses are being accepted only for the specific brands listed.

**Question 3:**

- **Person Asking:** Ron Thomas

- **Person Answering:** Jeremy Parker

- **Question:** If we have exclusivity over items, can we negotiate directly or must there still be a solicitation?

- **Answer:** All items will go through a solicitation for transparency; specific needs may prompt different decisions based on VA needs.

**Question 4:**

- **Person Asking:** Jason Pay

- **Person Answering:** Jeremy Parker

- **Question:** Can additional items be added to the list for a complete system?

- **Answer:** Yes, provide details of missing items in the comments, specifying they are part of a product family for review.

**Question 5:**

- **Person Asking:** Chris Holcomb

- **Person Answering:** Jeremy Parker

- **Question:** Should vendor-requested items with significant VA sales be included?

- **Answer:** Items on this RFI are specific to vision awards; another RFI may come later for other items.

**Question 6:**

- **Person Asking:** Kim

- **Person Answering:** Jeremy Parker

- **Question:** Is the RFI to clean up data prior to a new or existing solicitation?

- **Answer:** It is for a new solicitation; current item issues should be addressed through existing contracts.

**Question 7:**

- **Person Asking:** Michele

- **Person Answering:** Jeremy Parker

- **Question:** How to know if a product is offered by a validated supplier?

- **Answer:** No suppliers are listed in the RFI; responses should include supplier authorization details.

**Question 8:**

- **Person Asking:** Catherine

- **Person Answering:** Jeremy Parker

- **Question:** Do authorized distributors need to submit a new ADL for items already approved on a current BPA?

- **Answer:** Yes, a recent (within 90 days) ADL or acknowledgment via email is required.

**Question 9:**

- **Person Asking:** Brooks Hulitt (Outside the chat)

- **Person Answering:** Jeremy Parker & Crystal Martin

- **Question:** What should be done if a high-volume item related to a product family is missing from the RFI?

- **Answer:** Mark it as "other" in the spreadsheet and provide details in the comments section.

Additional items will be reviewed within the context of the product family.

**Question 10:**

- **Person Asking:** Camille Cherri (Outside the chat)

- **Person Answering:** Jeremy Parker & Crystal Martin

- **Question:** How do we distinguish what items should be on MSPV and what should not, regarding DME?

- **Answer:** Awaiting final legal definitions. Submit items thought to be DME for review and clarity will be provided when available.

**Question 11:**

- **Person Asking:** Erik Brinker (Outside the chat)

- **Person Answering:** Jeremy Parker & Crystal Martin

- **Question:** If an item is not a consumable and falls under reusable medical devices, how should it be identified?

- **Answer:** Provide feedback that the item might not fit the scope; further clarifications and decisions will be made based on additional legal definitions.

**Question 12:**

- **Person Asking:** Jackie (Outside the chat)

- **Person Answering:** Jeremy Parker

- **Question:** Does the OEM information take precedence over conflicting details provided?

- **Answer:** Yes, OEM information will be prioritized for accuracy.

### Final Summary:

**Jeremy Parker** concluded the industry day by emphasizing the need for accurate and comprehensive data responses to ensure the efficiency of the MSPV program. Responses will streamline the solicitations process, ensuring that the right supplies are available for VHA facilities.

The team assured attendees that slides and a summary of the call would be provided and thanked them for their participation. Crystal Martin also encouraged feedback on how to improve marketing and engagement for future solicitations.